Since 1995 our team has:

Participated in the development of > 50 Strategic Marketing Plans

Developed and Implemented Over:

80 Accredited Educational Programs
115 Advisory Boards
75 Publications
45 Experience Trials and Clinical Research Projects
110 Market Research Projects (including proprietary touchscreen system)

In addition, our studies have been covered and cited by Managed Care Consultant-First Report, MedPageToday.com, Medscape, and others.

Recent projects include:

Retrospective database studies:

Comparing the costs, absences, and adherence of products used to treat chronic conditions such as multiple sclerosis, rheumatoid arthritis, depression, diabetes, and others.

Focused on the incremental impact of various conditions on employees, using annual study timeframes, pre-/post designs, and others.

Examining the costs, prevalence, and services of standardized comorbidity categories associated with various conditions.

Comparisons of Fixed Dose Combination products with Lose Dose Combination products on costs, absence, and patient persistence with therapies.

Research on the impact of add-back therapy on patient compliance in persons with Endometriosis.

The impact of plan design and co-pays on patient persistence and adherence with therapies.

Using Medicaid data, annual timeframes, and pre-/post designs.

Clinical and Payor Advisory board programs for new and developmental products.

A 1250 patient / 300 physician launch study rolled out within 90 days of FDA approval (including legal/regulatory approval and all aspects of study design). Over 80% of the final (1 month) data was input, Q/A'd, and analyzed within 90 days of initial roll-out. This study also captured competitive market share. Conference papers were created as well.

An ongoing 9000 patient / 250 hospital observational study related to Community Acquired Pneumonia. Hospitals are given a report benchmarking their outcomes compared to the other sites participating in the study. Aggregate data is provided to the study sponsor on a regular basis, comparing their drug to competitors.

An IVR (Interactive Voice Response) telephonic system capturing outcomes and prescription utilization information weekly from 150 patients over a 12 month period. Regular compliance has been obtained in 85% of the patients enrolled. Our IVR system is used in five languages in four countries.

An ongoing market research program has been conducted at major medical conferences, capturing physician opinions and practice/prescribing patterns over the last six years. Typically 300-400 physicians are surveyed per conference. Reporting, including complete statistics, is typically done within a 48 hour turnaround.

Our expert advisory panels have helped lend credibility, and brought objective scientific knowledge to our client's marketing presentations. This in turn has streamlined the formulary approval process for our client's recently approved drugs.

An integrated 'Turn-Key' medical marketing campaign for a small pharma company, consisting of strategic consulting, expert speaker selection, a series of medical and pharmacist advisory boards, market research, sales training, and a Phase IV research